Optiver Holding
ORIC icon

Optiver Holding’s Oric Pharmaceuticals ORIC Stock Holding History

Optiver Holding’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Sell
248
-260
-51% -$2.36K ﹤0.01% 2221
2026
Q1 		$6.44K Buy
508
+256
+102% +$2.91K ﹤0.01% 1333
2025
Q4 		$2.06K Sell
252
-362
-59% -$4.17K ﹤0.01% 2005
2025
Q3 		$7.37K Buy
+614
New +$6.46K ﹤0.01% 1483

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Optiver Holding's ORIC Position: Q2 2026 in Review

Optiver Holding reduced its Oric Pharmaceuticals (ORIC) stake by 51% in Q2 2026, selling an estimated $2.36K and leaving 248 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Optiver Holding first reported a position in ORIC in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.37K in Q3 2025. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Optiver Holding held 248 shares of Oric Pharmaceuticals worth $2.69K as of Q2 2026.
  • Optiver Holding sold 260 Oric Pharmaceuticals shares in Q2 2026, an estimated $2.36K.
  • Oric Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2221 holding.
  • Optiver Holding first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Oric Pharmaceuticals position peaked at $7.37K in Q3 2025.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.